Peptide profile
Fat loss Clinical evidence
Retatrutide
Triple-action metabolic optimization
Compare Retatrutide with other peptides →Summary
Burn fat faster while feeling less hungry.
- Typical dose
- 2-4mg Weekly
- Route
- Subcutaneous
- Cycle length
- 12-16 weeks
- Evidence
- Clinical evidence
Reported in research
Benefits
- Accelerates fat loss
- Reduces appetite
- Improves insulin sensitivity
Context, not a prescription
Dosing
- Typical range
- 2-4mg Weekly (Subcutaneous)
- Cycle length
- 12-16 weeks
In depth
Full profile
What it does
Burn fat faster while feeling less hungry.
Good to know
- Accelerates fat loss
- Reduces appetite
- Improves insulin sensitivity
Overview
Burn fat faster while feeling less hungry.
Qué hace
Quema grasa más rápido mientras sientes menos hambre.
Bueno saber
- Acelera la pérdida de grasa
- Reduce el apetito
- Mejora la sensibilidad a la insulina
Descripción general
Quema grasa más rápido mientras sientes menos hambre.
Reference data
Specifications
- Route
- Subcutaneous
- Cycle length
- 12-16 weeks
FAQ
Common questions
What is the evidence level?
This compound is classified as Clinical evidence. Randomized controlled trial data in humans exists and supports use in specific contexts.
Research
Research & sources
Clinical evidence
Current evidence for Retatrutide is rated as Clinical evidence. Human clinical evidence supports the reported effects.
No primary sources listed yet.